Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 169

    1.

    Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.

    Fumeron F, Péan F, Driss F, Balkau B, Tichet J, Marre M, Grandchamp B; Insulin Resistance Syndrome (DESIR) Study Group.

    Diabetes Care. 2006 Sep;29(9):2090-4.PMID: 16936158 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Vari IS, Balkau B, Kettaneh A, André P, Tichet J, Fumeron F, Caces E, Marre M, Grandchamp B, Ducimetière P; DESIR Study Group.

    Diabetes Care. 2007 Jul;30(7):1795-801. Epub 2007 Apr 6.PMID: 17416791 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels.

    Bonnet F, Balkau B, Malécot JM, Picard P, Lange C, Fumeron F, Aubert R, Raverot V, Déchaud H, Tichet J, Lecomte P, Pugeat M; DESIR Study Group.

    Eur J Endocrinol. 2009 Jul;161(1):81-5. Epub 2009 May 8.PMID: 19429700 [PubMed - indexed for MEDLINE]Related articles

    4.

    Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study.

    Fumeron F, Aubert R, Siddiq A, Betoulle D, Péan F, Hadjadj S, Tichet J, Wilpart E, Chesnier MC, Balkau B, Froguel P, Marre M; Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group.

    Diabetes. 2004 Apr;53(4):1150-7.PMID: 15047634 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men.

    Sheu WH, Chen YT, Lee WJ, Wang CW, Lin LY.

    Clin Endocrinol (Oxf). 2003 Mar;58(3):380-5.PMID: 12608945 [PubMed - indexed for MEDLINE]Related articles

    6.

    The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study.

    Jaziri R, Lobbens S, Aubert R, Péan F, Lahmidi S, Vaxillaire M, Porchay I, Bellili N, Tichet J, Balkau B, Froguel P, Marre M, Fumeron F; DESIR Study Group.

    Diabetes. 2006 Apr;55(4):1157-62.PMID: 16567542 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.

    Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ.

    Diabetes. 2008 Oct;57(10):2619-25. Epub 2008 Jun 30.PMID: 18591391 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

    Diabetes Care. 2006 Jul;29(7):1619-25.PMID: 16801588 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.

    Cauchi S, Meyre D, Choquet H, Dina C, Born C, Marre M, Balkau B, Froguel P; DESIR Study Group.

    Diabetes. 2006 Nov;55(11):3189-92. Erratum in: Diabetes. 2006 Dec;55(12):3635. PMID: 17065361 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity.

    Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W.

    Diabetes Care. 2007 Mar;30(3):604-8.PMID: 17327328 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.

    Vaxillaire M, Cavalcanti-Proença C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P; DESIR Study Group.

    Diabetes. 2008 Aug;57(8):2253-7. Epub 2008 Jun 12.PMID: 18556336 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, Czernichow S, Fumeron F, Froguel P, Vaxillaire M, Cauchi S, Ducimetière P, Eschwège E.

    Diabetes Care. 2008 Oct;31(10):2056-61. Epub 2008 Aug 8.PMID: 18689695 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.

    Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, Marre M; DESIR Study Group.

    J Hypertens. 2008 Nov;26(11):2198-206.PMID: 18854761 [PubMed - indexed for MEDLINE]Related articles

    15.

    [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance]

    Stochmal A, Jasiak-Tyrkalska B, Stochmal E, Huszno B, Kawecka-Jaszcz K.

    Przegl Lek. 2007;64(6):410-5. Polish. PMID: 18159849 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prospective cohort study of the relationship of markers of insulin resistance and secretion with weight gain and changes in regional adiposity.

    Gould AJ, Williams DE, Byrne CD, Hales CN, Wareham NJ.

    Int J Obes Relat Metab Disord. 1999 Dec;23(12):1256-61.PMID: 10643681 [PubMed - indexed for MEDLINE]Related articles

    17.

    Changes in transferrin are related to changes in insulin resistance: the SLIM study.

    Roumen C, Feskens EJ, Jansen EH, Saris WH, Blaak EE.

    Diabet Med. 2008 Dec;25(12):1478-82.PMID: 19046249 [PubMed - indexed for MEDLINE]Related articles

    18.

    Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores.

    Fernández-Real JM, Equitani F, Moreno JM, Manco M, Ortega F, Ricart W.

    J Clin Endocrinol Metab. 2009 Mar;94(3):982-8. Epub 2008 Dec 30.PMID: 19116239 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

    André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwège E.

    Diabetes Metab. 2005 Dec;31(6):542-50.PMID: 16357802 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Serum ferritin is associated with visceral fat area and subcutaneous fat area.

    Iwasaki T, Nakajima A, Yoneda M, Yamada Y, Mukasa K, Fujita K, Fujisawa N, Wada K, Terauchi Y.

    Diabetes Care. 2005 Oct;28(10):2486-91.PMID: 16186284 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data